Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
130 Cards in this Set
- Front
- Back
- 3rd side (hint)
|
Vena Cava |
|
|
|
SA Node |
|
|
|
Right Atrium |
|
|
|
Right Ventricle |
|
|
|
Purkinje Fibers |
|
|
|
Left Atrium |
|
|
|
Left Ventricle |
|
|
|
Bundle of His |
|
|
What refers to diseases of the
heart and blood vessels? |
Cardiovascular Disease
|
|
|
What 6 things do
Cardiovascular Disease Drugs include? |
Cardiovascular Disease includes:
25% of the top 200 drugs, such as for: Hypertension Angina pectoris Coronary Artery Disease Cerebrovascular Accident (CVI) Congestive Heart Failure (CHF) |
|
|
What are 5 Dental Considerations concerning Cardiovascular Drugs?
|
Contraindications to Treatment
Vasoconstrictor Limit Infective Endocarditis Cardiac Pacemakers Relationship Between Periodontal Disease and Both Cardiovascular Disease and Stroke |
treatment limit infective cardiac relationship
|
|
What are 5 Contraindications to Treatment?
|
Acute or Recent Myocardial Infraction (MI)
Unstable or Recent Onset of Angina Pectoris Uncontrolled CHF Uncontrolled Arrhythmias Significant, Uncontrolled Hypertension |
|
|
Vasoconstrictor Limit:
The majority of cardiovascular patients should benefit from what in the local anesthetic agent? |
The majority of cardiovascular patients should benefit from the use of epinephrine in the local anesthetic agent
|
|
|
Vasoconstrictor Limit: What must the amount and effect of epinephrine administration be weighed against? |
|
|
|
Vasoconstrictor Limit:
Who may warrent limiting the dose of epinepherine to the cardiac dose? What is the cardiac dose? |
Limiting the dose (of epinephrine in the local anesthetic agent) to the cardiac dose may be warranted in a few severely affected patients.
The cardiac dose: 0.04mg |
|
|
Vasoconstrictor Limit: When should prophylactic antibiotics be prescribed? |
|
|
|
Infective Endocarditis - Prophylactic Antibiotic Indications (2007 AHA): What are the 5 Key points indicating prophylactic antibiotics. |
|
|
|
Infective Endocarditis -
Prophylactic Antibiotic Indications (2007 AHA): What are the 3 Specific, Serious Congenital Heart Defect? |
Unrepaired or incompletely repaired cyanotic CHD (palliative shunts and conduits)
Completely repaired congenital heart defect with prosthetic material or device during the first 6 months after the procedure (either by surgical or catheter placement) Any repaired congenital heart defect with residual defect at site or adjacent to site of a prosthetic patch or prosthetic device |
|
|
What is a cardiac pacemaker? |
|
|
|
Cardiac Pacemakers: What is NOT required for pacemakers? |
|
|
|
Cardiac Pacemakers: What is IMPORTANT to remember about pacemakers , shielding, and dentistry? |
|
|
|
Cardiac Pacemakers: What device could be dangerous to use around unshielded cardiac pacemakers? |
|
|
|
Cardiac Pacemakers: Although there are no reports of unltrasonic devices actually interfering with a cardiac pacemaker performance, what has a study shown? Does this affect them all the same? |
|
|
|
Cardiac Pacemakers: Who may have recommendations for use of ultrasonic devices on patients with cardiac pacemakers? Who may need consulted before treatment. |
|
|
|
Heart Failure: In CHF, what does the heart do or not do? |
|
|
|
Heart Failure: In CHF, why does the heart not provide adequate cardiac output? |
|
|
|
Heart Failure: What does left side failure lead to? |
|
|
|
Heart Failure: What does right side failure lead to? |
|
|
|
Heart Failure: What may be an ATC consideration for patients with CHF? |
|
|
|
Heart Failure Treatment: Once stabilized, what should be used as a first line therapy? |
|
|
|
Heart Failure Treatment: What should be used to treat fluid over load? What should be used to treat ischemic HF? |
|
|
|
Heart Failure Treatment:
What should be used to reduce afterload and preload? What are 3 given examples? |
Vasodilators to reduce afterload and preload
i.e. hydralazine and/or isosorbide dinitrate; Aldostrone antagonist (spironolactone) |
|
|
Heart Failure Treatment: What treatment should be avoided? Why? |
|
|
|
What is Digitalis Glycosides? |
|
|
|
Digitalis Glycosides: What are three considerations? |
|
|
|
Digitalis Glycosides:
In addituon to HF, what are 3 conditions it is used for? |
Used for Atrial arrhythmias, including atrial fibrillation, and paroxysmal atrial tachycardia
|
|
|
Digitalis Glycosides: What is used as the prototype? |
|
|
|
Digitalis Glycosides:
What affect does this have on the heart? |
Increases force and strength of contraction of the myocardium (positive inotropic effect)
|
|
|
What are 4 ways that Digitalis Glycosides's affect on the heart act as a treatment of CHF? |
|
|
|
Adverse Reactions of Digitalis Glycosides: What can trigger toxic symptoms? |
|
|
|
Adverse Reactions of Digitalis Glycosides: What are the GI signs of toxicity? |
|
|
|
Adverse Reactions of Digitalis Glycosides: Which two Digitalis Glycosides toxicity can cause predisposition to arrhythmias?
|
|
|
|
Adverse Reactions of Digitalis Glycosides: What are the neurologic signs of toxicity? |
|
|
|
Adverse Reactions of Digitalis Glycosides: Which dental drug interactions can increase the chances of arrhythmia in patients with severe cardiac disease? |
--The epinephrine dose may be limited to the cardiac dose (0.04mg) |
|
|
Adverse Reactions of Digitalis Glycosides: What antibiotics may increase digoxin levels? |
|
|
|
Antiarrythmatic Agents: What may arrhythmias result from? |
|
|
|
Antiarrythmatic Agents: How do antiarrhythmatic agents work? |
|
|
|
Antiarrythmatic Agents: What are three ways antiarrhythmatic agents depress parts of the heart that are beating abnormally? |
They may:
|
|
|
Antiarrythmatic Agents: What are two draw backs of antiarrhythmatic agents? |
|
|
|
Antiarrythmatic Agents: Which patients are antiarrhythmatic agents used for? |
|
|
|
Automaticity:
What is automaticity? |
The intrinsic rhythm that cardiac muscle cells have
|
|
|
Automaticity:
Which node has the fastest rate of depolarization and directs other cells of the heart? |
The sinoatrial (SA) node in the right atrium has the fastest rate of depolarization and directs other cells of the heart
|
|
|
Automaticity: Which nervous system is the sinoatrial (SA) node innervated by? |
|
|
|
Automaticity: Which node is signaled by the sinoatrial (SA) node? |
|
|
|
Automaticity: What does the artioventricular (AV) node send signals through? |
|
|
|
Automaticity: Where does the artioventricular (AV) node sends signals to through the bundle of his? |
|
|
|
Automaticity - Action Potentioal: What is an action potential generated by? |
|
|
|
Automaticity - Action Potential: What is an action potential visualized as? |
|
|
|
Automaticity - Action Potential: A relationship exists between the action potential and what? |
|
|
|
What is digoxin used to treat? |
|
|
|
Antiarrhythmic Agents: What is digoxin not included in? |
|
|
|
Antiarrhythmic Agents:
What are 3 reasons digoxin is used to treat arrhythmia? |
Digoxin:
decreases rate of the sinoatrial (SA) node slows atrioventricular (AV) node conduction prolongs refractory period of the AV node -- Reduces number of impulses transmitted to the ventricle resulting in a decreased heart rate |
|
|
Antiarrhythmic Agents - Classification and Mechanism of Action: What is the MOA of Class IA and which drugs does this class include? |
|
|
|
Antiarrhythmic Agents - Classification and Mechanism of Action: What is the MOA of Class IB and which drugs does this class include? |
|
|
|
Antiarrhythmic Agents - Classification and Mechanism of Action: What is the MOA of Class IC and which drugs does this class include? |
|
|
|
Antiarrhythmic Agents - Classification and Mechanism of Action: What is the MOA of Class II and which drugs does this class include? |
|
|
|
Antiarrhythmic Agents - Classification and Mechanism of Action: What is the MOA of Class III and which drugs does this class include? |
|
|
|
Antiarrhythmic Agents - Classification and Mechanism of Action: What is the MOA of Class IV and which drugs does this class include? |
|
|
|
Aniarrhythmatic Agents -
Management of Dental Patients: What should you check for on ALL antiarrhythmatic agent-taking patients? |
All: abnormal or extra beats when taking blood pressure and pulse?
|
|
|
Aniarrhythmatic Agents - Management of Dental Patients: What should you check for on AF patients taking warfarin? |
|
|
|
Aniarrhythmatic Agents - Management of Dental Patients: What should you check for on patients who are taking calcium channel blockers (CCBs)? |
|
|
|
Aniarrhythmatic Agents - Management of Dental Patients: What should you check for on patients who are taking Class IA drugs? |
|
|
|
Aniarrhythmatic Agents - Management of Dental Patients: What should you check for on patients taking Quinidine? |
|
|
|
Aniarrhythmatic Agents - Management of Dental Patients: What should you check for on patients taking Phenytoin? |
|
|
|
Aniarrhythmatic Agents - Management of Dental Patients: What do beta-blockers interact with? |
|
|
|
Angina Pectoris: What is angina pectoris characterized by? |
|
|
|
Angina Pectoris: Besides the left arm and shoulder, where else can the chest pain or discomfort radiate to and what can it be confused with? |
|
|
|
Angina Pectoris:
When does angina pectoris occure? |
Occurs when coronary arteries do not supply enough oxygen to the myocardium
|
|
|
Angina Pectoris: At one time, what were the only drugs that could relieve the symptoms of angina pectoris? |
|
|
|
Angina Pectoris: Today, what has added a new dimension to relieving angina pectoris symptoms? |
|
|
|
Angina Pectoris: What is the effect of NTG-like compounds, beta-adregenic blockers and calcium channel blockers (CCBs)? |
|
|
|
Angina Pectoris:
How do the NTG-like compounds, beta-adrenergic blockers and calcium channel blockers (CCBs) reduce painful symptoms and the workload of the heart? |
Oxygen requirements of myocardium is reduced, relieving painful symptoms
Reduce workload by decreasing cardiac output and/or peripheral vascular resistance |
|
|
Nitroglycerin-Like Compounds: What is NTG the most often used nitrate for? |
|
|
|
Nitroglycerin-Like Compounds: Is NTG a vasodilator or vasoconstrictor? |
|
|
|
Nitroglycerin-Like Compounds: What does NTG release? |
|
|
|
Nitroglycerin-Like Compounds: By reducing workload on the heart, what does NTG do? |
|
|
|
Nitroglycerin-Like Compounds: What is Amyl nitrate? |
|
|
|
Nitroglycerin-Like Compounds: How is amyl nitrate administered? |
|
|
|
Nitroglycerin-Like Compounds:
Is amyl nitrate often used? why |
It is not often used due to abuse potential
|
|
|
Nitroglycerin-Like Compounds: What Sublingual (SL) NTG is available? |
|
|
|
Nitroglycerin-Like Compounds:
Besides nitrostat and nitroingual, what other SL is also effective for an acute anginal attack? |
SL isosorbide dinitrate is also effective for an acute anginal attack
|
|
|
Nitroglycerin-Like Compounds: Where should this be kept in a dental office? |
|
|
|
Nitroglycerin-Like Compounds: What should patients who use NTG do at each appointment? |
|
|
|
Nitroglycerin-Like Compounds: What do most NTG adverse reactions effect? |
|
|
|
Nitroglycerin-Like Compounds: What are 5 symptoms that can result from adverse reactions? |
|
|
|
Nitroglycerin-Like Compounds - Drug Interactions/Contraindications: What are 3 inhibitors of phosphodiesterase 5 (PDE5)? What are they also used for? |
|
|
|
Nitroglycerin-Like Compounds - Drug Interactions/Contraindications: The administration of administration of PDE5 inhibitors are contraindicated with what? Why? |
|
|
|
Nitroglycerin-Like Compounds: What are nitroglycerin-like compounds degraded by? What are they not degraded by? |
|
|
|
Nitroglycerin-Like Compounds: What should tablets be stored in? |
|
|
|
Nitroglycerin-Like Compounds: How long is NTG good for? |
|
|
|
Nitroglycerin-Like Compounds: What are long-acting NTG-like products available for? Dose forms include what? |
|
|
|
Nitroglycerin-Like Compounds: What occurs with long-term regular use of NTG like products? |
|
|
|
Nitroglycerin-Like Compounds: What should prophylactic nitrates be given with? |
|
|
|
Nitroglycerin-Like Compounds: What does mononitrate dose form require? |
|
|
|
Nitroglycerin-Like Compounds: What 3 types of long acting nitates have prophylactic use? |
|
|
|
Nitroglycerin-Like Compounds:
Besides long-acting nitrates, which NTG-like compounds have prophylactic use? |
Beta-blockers - Propranolol
Calcium Channel blockers (CCBs) |
|
|
Calcium Channel Blocking Agents: What does the MOA of CCBs inhibit? |
|
|
|
Calcium Channel Blocking Agents:
What results from the MOA of CCB's? |
Vasodilation and a decrease in peripheral resistance results, decreasing the workload of the heart
|
|
|
Calcium Channel Blocking Agents:
What are the two broad categories? |
Non-dihydropyridines and dihydropyridines
|
|
|
Calcium Channel Blocking Agents:
What do Non-dihydropyridines include? What do they cause? |
Non-dihydropyridines include verapamil and diltiazem
Coronary vascular smooth muscle relaxation and coronary vasodilation Depresses activity of SA and AV nodes (direct myocardial activity) |
|
|
Calcium Channel Blocking Agents:
What do dihydropyridines include? What do they cause? |
Dihydropyridines include nifedipine and other "...pines"
Affect vascular smooth muscle and myocardium (peripheral arterial vasodilation, coronary vascular smooth muscle relaxation and vasodilation) Reflex tachycardia |
|
|
Calcium Channel Blocking Agents: What are CCBs also used to treat?
|
|
|
|
Calcium Channel Blocking Agents: What do adverse effects include? What is Nifedipine associated with? |
|
|
|
Beta-Adrenergic Blocking Agents: What are beta-adrenergic blocking agents used for? |
|
|
|
Beta-Adrenergic Blocking Agents: What do they block? What does this reduce? |
|
|
|
Beta-Adrenergic Blocking Agents: What is the net result of their use? |
|
|
|
Beta-Adrenergic Blocking Agents: What do 6 adverse effects include? |
|
|
|
Beta-Adrenergic Blocking Agents:
What 3 drugs are included in this category? |
propranolol, metroprolol, atenolol
|
|
|
ranolazine (Ranexa): What is ranolazine (Ranexa)? |
|
|
|
ranolazine (Ranexa): What is its MOA and which patients should it be used in? |
|
|
|
Treatment of an Acute Angina Attack: before administering NTG? |
|
|
|
Treatment of an Acute Angina Attack: If the patient has used PDE5 inhibitor within the past 24 hours, what should be done? |
|
|
|
Treatment of an Acute Angina Attack: What should be available? |
|
|
|
Treatment of an Acute Angina Attack: What is not useful for treatment of acute anginal attack? |
|
|
|
Treatment of an Acute Angina Attack: What should the dental office have for acute emergencies? |
|
|
|
Treatment of an Acute Angina Attack: How should NTG be administered? |
|
|
|
Treatment of an Acute Angina Attack: What should be done if the anginal attack is not stopped after 3 tablets or doses? |
|
|
|
Prevention of Anginal Attack: What are 2 methods of preventing an acute anginal attack? |
|
|
|
Treatment of an Acute Angina Attack: Which anxiolytic may be prescribed and why? |
|
|
|
Treatment of an Acute Angina Attack: What does using SL NTG to premedicate and anxious patient do? When should this not be used? |
|
|